i
i
Up-to-date Information
Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html
CDC Novavax COVID-19 vaccination operational planning guide
-
July 19, 2022
Details:
-
Corporate Authors:
-
Description:On July 13, 2022, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Novavax COVID-19 vaccine for use among people ages 18 years and older for primary series vaccination. On July
19, 2022, CDC’s Advisory Committee on Immunization Practices (ACIP) recommended use of the Novavax COVID19 vaccine in this population.
The Novavax COVID-19 vaccine is administered as a two-dose primary series, with the doses given 3 weeks apart. A limited number of doses of Novavax COVID-19 vaccine will be distributed and not all providers are expected to
carry Novavax COVID-19 vaccine. This operational planning guide includes details about the anticipated Novavax product.
Novavax-COVID-19-Vaccination-Operational-Planning-Guide.pdf
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +